Scientific and Clinical Validation
- Cannabidiol (CBD) is known to exist in polymorphic states and has a low melting point, poor absorption and bioavailability (learn more about polymorphism)
- CBD is a proven treatment for epilepsy and is used in a medicine to treat spasticity in Multiple Sclerosis (MS)
- Strong preclinical and clinical evidence supports treatment with CBD in numerous anxiety disorders
- Cocrystalization is a well-established, solid-state approach to improve physicochemical properties of pharmaceutical ingredients, including polymorphism, bioavailability, absorption, melting point, consistency and chemical stability
- Numerous approved drugs are cocrystals
- Strong preclinical evidence supports treatment with CBD in cancer
- Ongoing pre-clinical studies in cancer and anxiety